Wnt-signaling mediates the anti-adipogenic action of lysophosphatidic acid through cross talking with the Rho/Rho associated kinase (ROCK) pathway

Biochemistry and Cell Biology

Volumn 89, Issue 6, 2011, Pages 515-521

  Li, L ^a   Tam, L ^a   Liu, L ^a   Jin, T ^b   Ng, D S ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

3T3 L1; Adipogenesis; Lysophosphatidic acid; RhoA; Wnt signaling

Indexed keywords

3T3-L1; ADIPOGENESIS; LYSOPHOSPHATIDIC ACID; RHOA; WNT-SIGNALING;

CELLS; CYTOLOGY; ENZYMES; GENES; PHOSPHOLIPIDS;

ROCKS;

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BETA CATENIN; FASUDIL; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RHO FACTOR; RHO KINASE; WNT PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; 3T3 CELLS; ADIPOGENESIS; AMIDES; ANIMALS; BETA CATENIN; GENE EXPRESSION REGULATION; LYSOPHOSPHOLIPIDS; MICE; PPAR GAMMA; PYRIDINES; RECEPTOR CROSS-TALK; RHO-ASSOCIATED KINASES; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84863155206     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o11-048     Document Type: Article

References (21)

1. Amano M. Nakayama M. Kaibuchi K. 2010. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken), 67 (9): 545-554. 20803696
2. Angers S. Moon R.T. 2009. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10 (7): 468-477. 19536106
3. Cawthorn W.P. Heyd F. Hegyi K. Sethi J.K. 2007. Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ. 14 (7): 1361-1373. 10.1038/sj.cdd.4402127 17464333
4. Choi J.W. Lee C.W. Chun J. 2008. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim. Biophys. Acta, 1781 (9): 531-539. 18407842
5. Dusaulcy R. Daviaud D. Pradère J.P. Grès S. Valet P. Saulnier-Blache J.S. 2009. Altered food consumption in mice lacking lysophosphatidic acid receptor-1. J. Physiol. Biochem. 65 (4): 345-350. 10.1007/BF03185929 20358347
6. Dusaulcy R. Rancoule C. Grès S. Wanecq E. Colom A. Guigné C. et al. 2011. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J. Lipid Res. 52 (6): 1247-1255. 10.1194/jlr.M014985 21421848
7. Ferry G. Tellier E. Try A. Grés S. Naime I. Simon M.F. et al. 2003. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J. Biol. Chem. 278 (20): 18162-18169. 10.1074/jbc.M301158200 12642576
8. Jin T. 2008. The WNT signalling pathway and diabetes mellitus. Diabetologia, 51 (10): 1771-1780. 10.1007/s00125-008-1084-y 18696049
9. Jin T. Liu L. 2008. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol. Endocrinol. 22 (11): 2383-2392. 10.1210/me.2008-0135 18599616
10. Lagathu C. Christodoulides C. Virtue S. Cawthorn W.P. Franzin C. Kimber W.A. et al. 2009. Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/β-catenin signaling network. Diabetes, 58 (3): 609-619. 10.2337/db08-1180 19073771
11. Li L. Naples M. Song H. Yuan R. Ye F. Shafi S. et al. 2007. LCAT-null mice develop improved hepatic insulin sensitivity through altered regulation of transcription factors and suppressors of cytokine signaling. Am. J. Physiol. Endocrinol. Metab. 293 (2): E587-E594. 10.1152/ajpendo.00278.2007 17551001
12. Longo K.A. Wright W.S. Kang S. Gerin I. Chiang S.H. Lucas P.C. et al. 2004. Wnt10b inhibits development of white and brown adipose tissues. J. Biol. Chem. 279 (34): 35503-35509. 10.1074/jbc.M402937200 15190075
13. MacDonald B.T. Tamai K. He X. 2009. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 17 (1): 9-26. 10.1016/j.devcel.2009.06.016 19619488
14. Noguchi M. Hosoda K. Fujikura J. Fujimoto M. Iwakura H. Tomita T. et al. 2007. Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. J. Biol. Chem. 282 (40): 29574-29583. 10.1074/jbc.M705972200 17681946
15. Otto T.C. Lane M.D. 2005. Adipose development: from stem cell to adipocyte. Crit. Rev. Biochem. Mol. Biol. 40 (4): 229-242. 10.1080/ 10409230591008189 16126487
16. Pagès G. Girard A. Jeanneton O. Barbe P. Wolf C. Lafontan M. et al. 2000. LPA as a paracrine mediator of adipocyte growth and function. Ann. N.Y. Acad. Sci. 905: 159-164. 10818451
17. Qadir A.S. Lee H.L. Baek K.H. Park H.J. Woo K.M. Ryoo H.M. Baek J.H. 2011. Msx2 is required for TNF-α-induced canonical Wnt signaling in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 408 (3): 399-404. 10.1016/j.bbrc.2011.04.029 21514273
18. Sengupta S. Wang Z. Tipps R. Xu Y. 2004. Biology of LPA in health and disease. Semin. Cell Dev. Biol. 15 (5): 503-512. 10.1016/j.semcdb.2004.05.003 15271295
19. Simon M.F. Daviaud D. Pradère J.P. Grès S. Guigné C. Wabitsch M. et al. 2005. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor γ2. J. Biol. Chem. 280 (15): 14656-14662. 10.1074/jbc.M412585200 15710620
20. van Meeteren L.A. Moolenaar W.H. 2007. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 46 (2): 145-160. 10.1016/j.plipres.2007.02.001 17459484
21. Vertino A.M. Taylor-Jones J.M. Longo K.A. Bearden E.D. Lane T.F. McGehee R.E. Jr et al. 2005. Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol. Biol. Cell, 16 (4): 2039-2048. 10.1091/mbc.E04-08-0720 15673614